Nature of the Business and Basis of Presentation - Narrative1 (Details) - USD ($) $ / shares in Units, $ in Thousands					12 Months Ended			16 Months Ended
	Nov. 09, 2023	Oct. 20, 2023	Aug. 26, 2022	Jun. 10, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2023	Jun. 09, 2021
Schedule of Equity Method Investments [Line Items]
Common stock, par value (in dollars per share)			$ 0.0001
Total proceeds				$ 150,000	$ 53,136			$ 70,339
Price per share of stock sold (in dollars per share)									$ 10.00
Warrants to purchase Class G units
Schedule of Equity Method Investments [Line Items]
Warrants issued (in shares)		24,658,461
Percentage of outstanding warrants		90.00%
Tendered Warrants
Schedule of Equity Method Investments [Line Items]
Percentage of outstanding warrants		89.80%
Exercise price (in dollars per share)		$ 0.285
Untendered Warrants
Schedule of Equity Method Investments [Line Items]
Warrants issued (in shares)	2,741,426
Class A
Schedule of Equity Method Investments [Line Items]
Common stock, par value (in dollars per share)					$ 0.1000	$ 0.1000		$ 0.1000
Number of shares issued in transaction (in shares)				15,000,000	5,219,500			7,351,259
Price per share of stock sold (in dollars per share)					$ 10.18			$ 10.18
Issuance cost					$ 1,136
Issuance in connection with At-The-Market equity offering (in shares)	703,175	7,027,517
Converted ratio		0.2565
Difference between conversion ratio and exchange ratio		10.00%
Class A | Purchase price — equity consideration issuable (common stock)
Schedule of Equity Method Investments [Line Items]
Issuance in connection with At-The-Market equity offering (in shares)		7,027,517		44,797,894	5,219,500	2,131,759	1,725,000
Class A | Since Inception
Schedule of Equity Method Investments [Line Items]
Price per share of stock sold (in dollars per share)					$ 9.57			$ 9.57
At-The-Market Offering
Schedule of Equity Method Investments [Line Items]
Sale of stock, aggregate sales price			$ 150,000
Sale of stock, shares reserved for future issuance								$ 79,661